IQVIA | LinkedIn (original) (raw)

About us

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

Industry

Hospitals and Health Care

Company size

10,001+ employees

Headquarters

Durham, North Carolina

Type

Public Company

Specialties

Technology, Consulting, and Clinical Development

Locations

Employees at IQVIA

Updates

In the context of the World AMR Awareness Week, it’s necessary to highlight the importance of collecting and processing data through standard methods to better inform national #antibiotic policies and, in turn, provide a stronger rationale for domestic and global access targets. At IQVIA's recent side event hosted during #UNGA79, we discussed the need for high-quality, integrated data to understand antibiotic use and access gaps. Find out more in our latest blog:https://bit.ly/3YXH2xB #AntimicrobialResistance #AMR #WAAW
Knowing how to navigate the new Joint Scientific Consultation (JSC) process will be essential in the evolving EU HTA landscape. JSC offers health technology developers (HTDs) the opportunity to optimize evidence packages to satisfy future Joint Clinical Assessment (JCA) requirements – but what do you need to know before applying? Read our latest blog to discover strategies for maximizing the value of scientific consultation with HTA bodies.https://bit.ly/4evFqRo
2,138,999 followers
3d Edited
The IQVIA team is looking forward to connecting with you at ISPOR EU in Barcelona! Don’t miss our 4 live presentations on November 18 and 19, featuring IQVIA’s Richard Bergstrom, Georgios Nikolaidis, Julia Gallinaro, and Sophie Jouaville Abrouk, as well as 115+ posters featuring our research. Visit our booth to learn more about our latest RWE approaches, EU HTA information and see a live demo of our Health Research Space and Market Access Insights solutions.https://lnkd.in/gHkp65r8
Life sciences and the pharmaceutical industry is evolving rapidly. Our upcoming webinar, "Nine for 2025," will cover critical topics like the advancement of AI in healthcare, what therapeutic breakthroughs we can expect in the next year, and the future of the obesity market to name a few. Stay ahead of the curve and register nowhttps://bit.ly/3UPFQLk
Are you ready to make a difference in healthcare with your AI and Machine Learning skills? IQVIA is looking for talented individuals to innovate and transform the industry. Check out our exciting career opportunities and learn more about our AIML careers here: https://bit.ly/4fNW7st
“Defining and Analyzing Patient-centric Endpoints Based on COAs and Digital Technologies” is designed to establish an authoritative text on how to robustly analyze clinical outcome assessment (COA) data. Access this educational series here: https://bit.ly/48P1Sn9
Actionable insights from an assistant you can trust. Introducing IQVIA AI Assistant, a conversational AI interface, built on IQVIA Healthcare-grade AI™. Get started today: https://bit.ly/48Qp0lh
The rare disease segment is full of innovation, but the launch environment remains uniquely challenging, with added complexities of launching orphan medicines. Discover how the three pillars of launch excellence evolve in rare diseases: stakeholder engagement, health system readiness, and value evidence in this white paperhttps://bit.ly/4hL3oLd
This Veterans Day, we honor all U.S. veterans for their service. At IQVIA, we're grateful for the unique strengths our veterans bring to our mission of accelerating innovation for a healthier world and our Veterans Employee Resource Group (VERG) is dedicated to supporting their growth and success. Learn more: https://lnkd.in/g7KWzSer

Join now to see what you are missing

Join now

Affiliated pages

Browse jobs

Stock

IQV

November 16, 2024

NYSE

20 minutes delay

Open

202.02

Low

189.63

High